A new pharmaceutical advocacy group has made clear its support for exorbitant list prices for prescription drugs, entering an arena in which a number of organizations are looking for ways to cut prices.
According to a STAT report, little is known about the Alliance to Protect Medical Innovation, including who is funding the group which describes itself as a nonpartisan 501(c)(4) nonprofit.
“More life-changing medicines are available to patients now than ever before, with new medical breakthroughs treating – and even curing – once-untreatable conditions and diseases,” the “About Us” section on the group’s website states. “This type of innovation depends on the commitment of scientists, doctors, researchers, patients, investors, business leaders and others who are devoted to the discovery and development of new treatments and cures. However, access to the next generation of medicine is being threatened by short-sighted policy proposals that would chill investment in biomedical research and stifle the future innovation that so many patients continue to need.”
The organization appears to have launched a Twitter account (@ProtectMedicine) some time in August, though its first tweet was published Sept. 28.
To visit the organization’s website, click here.